Investment
Features
FeesSafety
Academy
More
Pluang+

Elon Musk pledges to give SpaceX shares to every American child next year, starting a new giveaway trend.

Market News
19 Oct 2026
New York Post
View Source
Bullish
Elon Musk pledges to give SpaceX shares to every American child next year, starting a new giveaway trend.

Elon Musk announced he will give one SpaceX share to every child in the U.S. next year, totaling about 72 million shares worth roughly $10.5 billion. This unprecedented giveaway aims to distribute wealth directly to the public, contrasting with other companies' plans to allocate shares to public benefit funds. Musk's promise highlights his vision for broad wealth sharing and could set a new precedent for private wealth distribution. Details on how the shares will be allocated remain unclear.

Elon Musk's SpaceX shares giveaway is notable context for readers. For those tracking Technology-sector stocks on Pluang, 107 of 150 stocks rose and 22 fell as of Oct 19, 2026 17:02 WIB. Key movers include CRDO at USD 176.57 (+4.05%), TER at USD 338.05 (+4.02%), and INTC at USD 93.42 (+3.97%).

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
24 minutes ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
24 minutes ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
24 minutes ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
24 minutes ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
24 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App